Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > James Mark Litton > Profile

James Mark Litton

Affiliations

  • President And Ceo at Athira Pharma Inc. (ATHA), 2025-03-04
  • See Remarks at Alpine Immune Sciences Inc. (ALPN), 2019-02-08
  • Chief Business Officer at Alder Biopharmaceuticals Inc (ALDR), 2018-06-05
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ATHA $0.56 25,107 $14,107.62 242,591 2025-01-02 Filing
ATHA $0.57 5,032 $2,848.11 159,365 2024-09-05 Filing
ATHA $2.91 4,820 $14,026.20 144,397 2024-01-05 Filing
ATHA $2.91 4,820 $14,026.20 144,397 2024-01-05 Filing
ATHA $2.69 7,960 $21,412.40 128,555 2022-06-23 Filing